MMNFQ (MedMen Enterprises) Notes Receivable: $0.0 Mil (As of Mar. 2023)


What is MedMen Enterprises Notes Receivable?

MedMen Enterprises MMNFQ -90.00% Notes Receivable is $0.0 Mil as of Mar. 2023.

MedMen Enterprises's Notes Receivable for the quarter that ended in Mar. 2023 was $0.0 Mil.

MedMen Enterprises's annual Notes Receivable increased from Jun. 2020 ($0.00 Mil) to Jun. 2021 ($1.34 Mil) but then declined from Jun. 2021 ($1.34 Mil) to Jun. 2022 ($1.19 Mil).

MedMen Enterprises Notes Receivable Related Terms

MedMen Enterprises Notes Receivable Historical Data

* Premium members only.

The historical data trend for MedMen Enterprises's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises Notes Receivable Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.34 1.19

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.19 0.00 0.00 0.00

MedMen Enterprises Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.0 Mil mean?
MedMen Enterprises (MMNFQ) has a Notes Receivable of $0.0 Mil as of Mar. 2023. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on MedMen Enterprises and its competitors.
Is MedMen Enterprises' Notes Receivable too high?
MedMen Enterprises' current Notes Receivable is $0.0 Mil.
How does MedMen Enterprises' Notes Receivable compare to ZTS and VTRS?
MedMen Enterprises' Notes Receivable of $0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on MedMen Enterprises and its competitors. MedMen Enterprises's current Notes Receivable is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMen Enterprises stock overvalued right now?
MedMen Enterprises (MMNFQ) has a current Notes Receivable of $0.0 Mil. The current Notes Receivable is $0.0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For MedMen Enterprises (MMNFQ), the current Notes Receivable is $0.0 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMen Enterprises Business Description

Address 8740 S Sepulveda Boulevard, Suite 105, Los Angeles, CA, USA, 90045
MedMen Enterprises Inc is a American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Arizona, Massachusetts, and New York, the company has MedMen and LuxLyte brands offering cannabis in consumer-preferred product forms for medical and recreational use. It produces and curates the consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs.